Issue 16, 2007
From the journal:

Chemical Communications

Solvent inclusion in form II carbamazepine

Aurora J. Cruz Cabeza,a   Graeme M. Day,a   W. D. Samuel Motherwellb  and  William Jones*a  

* Corresponding authors

a The Pfizer Institute for Pharmaceutical Materials Science, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK
E-mail: wj10@cam.ac.uk
Tel: +44 1223 336468

b The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, UK

Abstract

We report on experimental and theoretical evidence for solvent inclusion in form II carbamazepine (R[3 with combining macron]) and discuss the implications for the formation and stability of this form.

Graphical abstract: Solvent inclusion in form II carbamazepine

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/B701299C
Article type
Communication
Submitted
29 Jan 2007
Accepted
07 Mar 2007
First published
20 Mar 2007

Chem. Commun., 2007, 1600-1602

Permissions

Request permissions

Solvent inclusion in form II carbamazepine

A. J. Cruz Cabeza, G. M. Day, W. D. S. Motherwell and W. Jones, Chem. Commun., 2007, 1600 DOI: 10.1039/B701299C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements